Subsequent Events

On June 8, 2015, the Company signed an investor relations and public relations agreement with TDM Financial for 60 days at a cost of $18,000.

On June 8, 2015, the Company issued 250,000 common shares valued at $50,000 at $0.19 per share to a third party ( 50,000 common shares) and to another third party ( 200,000 common shares) with respect to agreements signed on April 2, 2015 and May 27, 2015.

On June 11, Lexaria initiated the simultaneous filing of a U.S. utility patent application and an International patent application under the Patent Cooperation Treaty (PCT) procedure, both at the U.S. Patent and Trademark Office. These applications follow the Company’s 2014 and 2015 family of provisional patent application filings in the U.S. and serve two additional broad purposes.

On June 11, 2015, Lexaria Corp. (the “Company”) entered into a Letter of Intent dated June 10, 2015 with Shaxon Enterprises Ltd. to sell its 49% interest with the MMPR Burlington application number 10QMM0610. The Burlington project related with Joint Venture Agreement dated May 28, 2014 with Enertopia Corp. based on developing a business of legally producing, manufacturing, propagating, importing/exporting, testing, researching and developing marijuana at the Burlington Location. This Joint Venture is to be terminated based on the closing of a definitive agreement to be entered into pursuant to the terms of the Letter of Intent with Shaxon Enterprises Ltd. 500,000 restricted common shares issued to Enertopia Corp. at a deemed price of $0.40 held in escrow will be returned back to Lexaria Corp. treasury and cancelled. On June 24, 2015, the Share Purchase Agreement was signed with Shaxon Enterprises Ltd.